71.86
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Can Disc Medicine Inc. stock weather global recessionJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com
How Disc Medicine Inc. stock performs in interest rate cyclesQuarterly Profit Review & Detailed Earnings Play Alerts - newser.com
Backtesting results for Disc Medicine Inc. trading strategiesPortfolio Performance Report & High Return Trade Guides - newser.com
Is Disc Medicine Inc. stock trading near support levelsEarnings Beat & Safe Entry Zone Identification - newser.com
What MACD and RSI say about Disc Medicine Inc.July 2025 Institutional & Safe Capital Investment Plans - newser.com
Disc Medicine (NASDAQ:IRON) Director Kevin Bitterman Sells 71,961 Shares - MarketBeat
Price action breakdown for Disc Medicine Inc.Weekly Stock Summary & High Accuracy Investment Entry Signals - newser.com
Tick level data insight on Disc Medicine Inc. volatilityPortfolio Value Summary & Daily Entry Point Alerts - newser.com
Real time social sentiment graph for Disc Medicine Inc.July 2025 Review & Real-Time Market Sentiment Alerts - newser.com
Disc Medicine's (IRON) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Bitterman Kevin, director at Disc Medicine, sells $6.3m in shares - Investing.com Canada
Building trade automation scripts for Disc Medicine Inc.July 2025 PreEarnings & Verified Swing Trading Watchlists - newser.com
Using RSI to spot recovery in Disc Medicine Inc.Quarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com
Visual trend scoring systems applied to Disc Medicine Inc.2025 Geopolitical Influence & Detailed Earnings Play Alerts - newser.com
Momentum divergence signals in Disc Medicine Inc. chartTrade Analysis Summary & Reliable Price Breakout Alerts - newser.com
Real time pattern detection on Disc Medicine Inc. stockDip Buying & Reliable Entry Point Alerts - newser.com
Quantitative breakdown of Disc Medicine Inc. recent moveQuarterly Earnings Summary & Daily Oversold Bounce Ideas - newser.com
Disc Medicine (NASDAQ:IRON) Sets New 52-Week HighTime to Buy? - MarketBeat
Disc Medicine stock hits 52-week high at 69.38 USD By Investing.com - Investing.com Nigeria
Disc Medicine director Mona Ashiya resigns, board size reduced to eight - Investing.com
Disc Medicine Board Member Mona Ashiya Resigns - TipRanks
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Disc Medicine stock hits 52-week high at 69.38 USD - Investing.com
Identifying reversal signals in Disc Medicine Inc.Market Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Is Disc Medicine Inc. stock cheap at current valuationPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
Developing predictive dashboards with Disc Medicine Inc. data2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Is Disc Medicine Inc. showing signs of accumulation2025 Institutional Moves & Fast Exit and Entry Strategy Plans - newser.com
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is a relief rally coming for Disc Medicine Inc. holdersEarnings Miss & Stock Portfolio Risk Management - newser.com
What momentum shifts mean for Disc Medicine Inc.Weekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
Will Disc Medicine Inc. stock recover after recent dropEarnings Growth Summary & Daily Technical Forecast Reports - newser.com
Should you wait for a breakout in Disc Medicine Inc.2025 Market Outlook & Expert Curated Trade Setups - newser.com
Analyzing Disc Medicine Inc. with risk reward ratio charts2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
A Fresh Look at Disc Medicine’s Valuation After Bitopertin NDA Submission and Positive Phase 2 Data - Yahoo Finance
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP) - Sahm
Disc MedicineBiotech Stock On The Move With Multiple Near-Term Catalysts - RTTNews
Disc Medicine (NASDAQ:IRON) Sets New 1-Year HighHere's Why - MarketBeat
Disc Medicine submits NDA for bitopertin in erythropoietic porphyria By Investing.com - Investing.com Nigeria
Disc Medicine Announces Submission of New Drug Application - GlobeNewswire
Disc Medicine Announces Submission Of NDA For Bitopertin - Nasdaq
Disc Medicine Submits New Drug Application to FDA for Bitopertin to Treat Patients With Erythropoietic Protoporphyria - MarketScreener
Disc Medicine submits NDA for bitopertin in erythropoietic porphyria - Investing.com
자본화:
|
볼륨(24시간):